Author:
Shi Lu,Jiang Zheli,Zhang Bowen,Tang Congrong,Xu Ren-ai
Funder
Zhejiang Pharmaceutical Association Project
Natural Science Foundation of Zhejiang Province
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference14 articles.
1. Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor;Tap;N. Engl. J. Med.,2015
2. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy;Cannarile;J. Immunother. Cancer,2017
3. Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature;Giustini;Clin. Sarcoma Res.,2018
4. Pexidartinib: First Approval, Drugs;Lamb,2019
5. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial;Tap;Lancet,2019
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献